Maldescendus testis

Hormone Research

Volumn 51, Issue 6, 1999, Pages 261-269

  Toppari, Jorma ^a   Kaleva, Marko ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

Cryptorchidism; Germ cell; hCG treatment; Orchidopexy; Sertoli; Testis

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN DERIVATIVE; GONADORELIN; GONADORELIN DERIVATIVE; HORMONE ANALOG;

APOPTOSIS; BLOOD VESSEL INJURY; CANCER RISK; CELL DEGENERATION; CRYPTORCHISM; DRUG EFFICACY; GENE CONTROL; GENE MUTATION; GERM CELL; HOMEOBOX; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; MALE; MALE INFERTILITY; ORCHIDOPEXY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENTIATION; SIDE EFFECT; TESTIS CANCER; TESTIS SIZE; TREATMENT OUTCOME;

EID: 0033372195     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023412     Document Type: Review

References (94)

1. Heyns CF, Hutson JM: Historical review of theories on testicular descent. J Urol 1995:153: 754-767.
2. Levy JB, Husmann DA: The hormonal control of testicular descent. J Androl 1995:16:459-463.
3. Wensing CJG: Testicular descent in the rat and a comparison of this process in the rat with that in the pig. Anat Rec 1986:214:154-160.
4. Hutson JM, Williams MP, Fallat ME, Attah A: Testicular descent: New insights into its hormonal control. Oxf Rev Reprod Biol 1990;12: 1-56.
5. Van der Schoot P, Elger W: Androgen-induced prevention of the outgrowth of cranial gonadal suspensory ligaments in fetal rats. J Androl 1992:13:534-542.
6. Emmen JM, McLuskey A, Grootegoed JA, Brinkmann AO: Androgen action during male sex differentiation includes suppression of cranial suspensory ligament development. Hum Reprod 1998:13:1272-1280.
7. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM: Targeted disruption of the Insl3 gene causes bilateral cryplorchidism. Mol Endocrinol 1999; 13:681-691.
8. Kolon TF, Wiener JS, Lewitton M, Roth DR, Gonzales ET Jr, Lamb DJ: Analysis of homeobox gene HOXA10 mutations in cryptorchidism. J Urol 1999:161:275-280.
9. Satokata I, Benson G, Maas R: Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature 1995:374:460-463.
10. Rijli FM, Matyas R, Pellegrini M, Dierich A, Gruss P, Dolle P, Chambon P: Cryptorchidism and homeotic transformations of spinal nerves and vertebrae in Hoxa-10 mutant mice. Proc Natl Acad Sci USA 1995:92:8185-8189.
11. Hutson JM, Donahoe PK: The hormonal control of testicular descent. Endocr Rev 1986;7: 270-283.
12. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR: Genetic analysis of the müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dcv 1996:10:2577-2587.
13. Tran D, Picard JY, Vigier B, Berger R, Josso N: Persistence of müllerian ducts in male rabbits passively immunized against bovine anti-müllerian hormone during fetal life. Dev Biol 1986; 116:160-167.
14. Backhouse KM: Embryology of testicular descent and maldescent. Urol Clin North Am 1982:9:315-325.
15. Hutson JM, Baker M, Terada M, Zhou B, Paxton G: Hormonal control of testicular descent and the cause of cryptorchidism. Reprod Fertil Dev 1994:6:151-156.
16. Heyns CF, Human HJ, Wercly CJ, De Klerk DP: The glycosaminoglycans of the gubernaculum during testicular descent in the fetus. J Urol 1990:143:612-617.
17. Popper P, Ulibarri C, Micevych PE: The role of target muscles in the expression of calcitonin gene-related peptide mRNA in the spinal nucleus of the bulbocavernosus. Brain Res Mol Brain Res 1992:13:43-51.
18. Fentener van Vlissingen JM, van Zoelen EJ, Ursem PJ, Wensing CJ: In vitro model of the first phase of testicular descent: Identification of a low molecular weight factor from fetal testis involved in proliferation of gubernaculum testis cells and distinct from specified polypeptide growth factors and fetal gonadal hormones. Endocrinology 1988;123:2868-2877.
19. McMahon DR, Kramer SA, Husmann DA: Antiandrogen induced cryptorchidism in the pig is associated with failed gubernacular regression and epididymal malformations. J Urol 1995:154:553-557.
20. Hutson JM: Testicular feminization: A model for testicular descent in mice and men. J Pediatr Surg 1986:21:195-198.
21. Scorer CG: The descent of the testis. Arch Dis Child 1964;39:605-609.
22. John Radcliffe Hospital Cryptorchidism Study Group: Cryptorchidism: A prospective study of 7,500 consecutive male births, 1984-1988. Arch Dis Child 1992:67:892-899.
23. Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR: Prevalence and natural history of cryptorchidism. Pediatrics 1993:92:44-49.
24. Heinonen OP, Slone D, Shapiro S: Birth Defects and Drugs in Pregnancy, Littleton, Publishing Sciences Group. 1977.
25. Hecker WC, Hienz HA, Mengel W: Frühbehandlung des Maldescensus testis. Dtsch Med Wochenschr 1972:36:1325-1329.
26. Hedinger C: Histological data in cryptorchidism. Pediatr Adolesc Endocrinol 1979:6:3-13.
27. Hedinger CE: Histopathology of undescended testes. Eur J Pediatr 1982;139:266-271.
28. Cortes D, Thorup JM, Beck BL: Quantitative histology of germ cells in the undescended testes of human fetuses, neonates and infants. J Urol 1995;154:1188-1192.
29. Cortes D: Cryptorchidism - Aspects of pathogenesis, histology and treatment. Scand J Urol Nephrol Suppl 1998:196:1-54.
30. Giwercman A, Bruun E, Frimodt-Moller C, Skakkebaek NE: Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989;142:998-1001.
31. Huff DS, Hadziselimovic F, Duckett JW, Elder JS, Snyder HMcC 111: Germ cell counts in semithin sections of biopsies of 115 unilaterally cryptorchid testes. The experience from the Children's Hospital of Philadelphia. Eur J Pediatr 1987;146(suppl 2):25-27.
32. Huff DS, Hadziselimovic F, Snyder HMcC III, Duekett JW, Keating MA: Postnatal testicular maldevelopment in unilateral cryptorchidism. J Urol 1989;142:546-548.
33. McAleer IM, Packer MG, Kaplan GW, Scherz HC, Krous HF, Billman GF: Fertility index analysis in cryptorchidism. J Urol 1995;153: 1255-1258.
34. Schindler AM, Diaz P, Cuendet A, Sizonenko PC: Cryptorchidism: A morphological study of 670 biopsies. Helv Paediatr Acta 1987;42:145-158.
35. Saito S, Kumamoto Y: The number of spermatogonia in various congenital testicular disorders. J Urol 1989:141:1166-1168.
36. Kiesewetter WB, Shull WR, Fetterman GH: Histologic changes in the testis following anatomically successful orchidopexy. J Pediatr Surg 1969;4:59-65.
37. Puri P, Sparnon A: Relationship of primary site of testis to final testicular size in cryptorchid patients. Br J Urol 1990:66:208-210.
38. Yavetz H, Harash B, Paz G, Yogev L, Jaffa AJ, Lessing JB, Homonnai ZT: Cryptorchidism: Incidence and sperm quality in infertile men. Andrologia 1992;24:293-297.
39. Taskinen S, Wikström S: Effect of age at operation, location of testis and preoperative hormonal treatment on testicular growth after cryptorchidism. J Urol 1997:158:471-473.
40. Cortes D, Thorup J: Histology of testicular biopsies taken at operation for bilateral maldescended testes in relation to fertility in adulthood. Br J Urol 1991:68:285-291.
41. Hadziselimovic F, Herzog B, Hocht B, Hecker E, Miescher E, Buser M: Screening for cryptorchid boys risking sterility and results of long-term buserclin treatment after successful orchiopexy. Eur J Pediatr 1987;146(suppl 2):59-62.
42. Taskinen S, Hovatta O, Wikström S: Early treatment of Cryptorchidism, semen quality and testicular endocrinology. J Urol 1996:156: 82-84.
43. Chilvers C, Dudley NE, Gough MH, Jackson MB, Pike MC: Undescended testis: The effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg 1986:21:691-696.
44. Ludvig G, Potemps J: Der optimale Zeitpunkt der Behandlung des Kryptochismus. Dtsch Med Wochenschr 1975:100:680-683.
45. Mandat KM, Wieczorkiewicz B, Gubala-Kacala M, Sypniewski J, Bujok G: Semen analysis of patients who had orchidopexy in childhood. Eur J Pediatr Surg 1994:4:94-97.
46. Grasso M, Buonaguidi A, Lania C, Bergamaschi F, Castelli M, Rigatti P: Postpubertal Cryptorchidism: Review and evaluation of the fertility. Eur Urol 1991:20:126-128.
47. Puri P, O'Donnell B: Semen analysis of patients who had orchidopexy at or after seven years of age. Lancet 1988:ii:1051-1052.
48. Puri P, O'Donnell B: Semen analysis in patients operated on for impalpable testes. Br J Urol 1990;66:646-647.
49. Nistal M, Paniagua R: Infertility in adult males with retractile testes. Fertil Steril 1984:41:395-403.
50. Bonde JP, Ernst E, Jensen TK, Hjollund NH, Kolstad H, Henriksen TB, Scheike T, Giwereman A, Olsen J, Skakkebaek NE: Relation between semen quality and fertility: A population-based study of 430 first-pregnancy planners. Lancet 1998:352:1172-1177.
51. Abyholm T, Oian P, Gordeladze JO: True cryptorchidism and retractile testes in infertile men. Acta Eur Fertil 1986;17:15-18.
52. Carizza C, Antiba A, Palazzi J, Pistono C, Morana F, Alarcon M: Testicular maldescent and infertility. Andrologia 1990;22:285-288.
53. Cendron M, Keating MA, Huff DS, Koop CE, Snyder HM III, Duckett JW: Cryptorchidism, orchiopexy and infertility: A critical long-term retrospective analysis. J Urol 1989;142:559-562.
54. Gilhooly PE, Meyers F, Lattimer JK: Fertility prospects for children with cryptorchidism. Am J Dis Child 1984:138:940-943.
55. Lipschultz LI, Caminos-Torrcs R, Greenspan CS, Snyder PJ: Testicular function after orchidopexy for unilaterally undescended testis. N Engl J Med 1976:295:15-18.
56. Lee PA, O'Leary LA, Songer NJ, Bellinger MF, LaPorte RE: Paternity after cryptorchidism: Lack of correlation with age at orchidopexy. Br J Urol 1995:75:704-707.
57. Cortes D, Thorup JM, Lindenberg S: Fertility potential after unilateral orchiopexy: An age independent risk of subsequent infertility when biopsies at surgery lack germ cells. J Urol 1996; 156:217-220.
58. Møller H, Prener A, Skakkebæk NE: Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: Case-control studies in Denmark. Cancer Causes Control 1996;7:264-274.
59. Whitaker RH: Neoplasia in cryptorchid men. Semin Urol 1988;6:107-109.
60. Halme A, Kellokumpu-Lehtinen P, Lehtonen T, Teppo L: Morphology of testicular germ cell tumours in treated and untreated cryptorchidism. Br J Urol 1989:64:78-83.
61. Raja MA, Oliver RT, Badenoch D, Blandy JP: Orchidopexy and transformation of seminoma to non-seminoma. Lancet 1992:339:930.
62. Strader CH, Weiss NS, Daling JR, Karagas MR, McKnight B: Cryptorchism, orchiopexy. and the risk of testicular cancer. Am J Epidemiol 1988:127:1013-1018.
63. Pike MC, Chilvers C, Peckham MJ: Effect of age at orchidopexy on risk of testicular cancer. Lancet 1986;i:1246-1248.
64. Skakkebaek NE, Berthelsen JG, Giwereman A, Muller J:Carcinoma-in-situ of the test is: Possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987;10:19-28.
65. Skakkebaek NE, Berthelsen JG, Muller J: Carcinoma-in-situ of the undescended testis. Urol Clin North Am 1982:9:377-385.
66. Berthelsen JG, Skakkebaek NE: Value of testicular biopsy in diagnosing carcinoma in situ testis. Scand J Urol Nephrol 1981;15:165-168.
67. Giwercman A: Carcinoma-in-situ of the testis: Screening and management. Scand J Urol Nephrol Suppl 1992;148:1-47.
68. Schapiro B: Kann man mit Hypophysenvorderlappen den unterentwickelten männlichen Genitalapparat beim Menschen zum Wachstum anregen? Dtsch Med Wochenschr 1930; 56:1605-1607.
69. Pyörälä S, Huttunen NP, Uhari M: A review and meta-analysis of hormonal treatment of cryptorchidism. J Clin Endocrinol Metab 1995:80:2795-2799.
70. Adamsen S, Armison S, Borjesson B: Prospective evaluation of human chorionic gonadotropin in the treatment of cryptorchidism. Acta Chir Scand 1989:155:509-514.
71. Hesse V, Fischer G: Three injections of human chorionic gonadotropin are as effective as ten injections in the treatment of cryptorchidism. Horm Res 1988:30:193-197.
72. Palmer JM: The undescended testicle. Endocrinol Metab Clin North Am 1991:20:231-240.
73. Kass EJ, Kogan SJ, Manley C, Wacksman JA, Klykylo WM, Meza A: Timing of elective surgery on the genitalia in male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. Pediatrics 1996:97:590-594.
74. Redman JF: The staged orchiopexy: A critical review of the literature. J Urol 1977;117:113-114.
75. Steinhardt GF, Kroovand RL, Perlmutter AD: Orchiopexy: Planned two-stage technique. J Urol 1985;133:434-435.
76. Bloom DA: Two-step orchiopexy with pelviscopic clip ligation of the spermatic vessels. J Urol 1991:145:1030-1033.
77. Frey P, Bianchi A: Microvascular orchiopexy. Fur J Pediatr 1987;146(suppl 2):51-52.
78. Hazelbroek FW, Molenaar JC: The management of the impalpable testis by surgery alone. J Urol 1992:148:629-631.
79. Docimo SG: The results of surgical therapy tor cryptorchidism: A literature review and analysis. J Urol 1995:154:1148-1152.
80. Cendron M, Huff DS, Keating MA, Snyder HM III, Duckett JW: Anatomical, morphological and volumetric analysis: A review of 759 cases of testicular maldescent. J Urol 1993;149: 570-573.
81. Guiney EJ, Corbally M, Malone PS: Laparoseopy and the management of the impalpable testis. Br J Urol 1989:63:313-316.
82. Oesch I, Ransley PG: Unilaterally impalpable testis. Eur Urol 1988;13:324-326.
83. Andersson AM, Toppari J, Haavisto AM, Peterscn JH, Simell T, Simell O, Skakkebaek NE: Longitudinal reproductive hormone profiles in infants: Peak of inhihin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998:83:675-681.
84. Corbally MT, Quinn FJ, Guiney EJ: The effect of two-stage orchiopexy on testicular growth. Br J Urol 1993:72:376-378.
85. Zer M, Wolloch Y, Dintsman M: Staged orchiorrhaphy. Therapeutic procedure in cryptorchic testicle with a short spermatic cord. Arch Surg 1975;110:387-390.
86. Zerella JT, McGill LC: Survival of nonpalpable undescended testicles after orchiopexy. J Pediatr Surg 1993:28:251-253.
87. Hjertkvist M, Bergh A, Damber JE: HCG treatment increases intratesticular pressure in the abdominal testis of unilaterally cryptorchid rats. J Androl 1988:9:116-120.
88. Kerr JB, Sharpe RM: Focal disruption of spermatogenesis in the testis of adult rats after a single administration of human chorionic gonadotrophin. Cell Tissue Res 1989:257:163-169.
89. Hjertkvist M, Läckgren G, Ploen L, Bergh A: Does HCG treatment induce inflammation-like changes in undescended testes in boys? J Pediatr Surg 1993:28:254-258.
90. Kaleva M, Arsalo A, Louhimo I, Rapola J, Perheentupa J, Henriksen K, Toppari J: Treatment with human chorionic gonadotrophin for cryptorchidism: Clinical and histological effects. Int J Androl 1996:19:293-298.
91. Maddock WO, Nelson WO: The effects of chorionic gonadotropin in adult men: Increased estrogen and 17-ketosteroid excretion, gynecomastia. Leydig cell stimulation and seminiferous tubule damage. J Clin Endocrinol Metab 1952:12:985-1007.
92. Heiskanen P, Billig H, Toppari J, Kaleva M, Arsalo A, Rapola J, Dunkel L: Apoptotic cell death in the normal and cryptorchid human testis: The effect of human chorionic gonadotropin on testicular cell survival. Pediatr Res 1996:40:351-356.
93. Dunkel L, Taskinen S, Hovatta O, Tilly JL, Wikström S: Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J Clin Invest 1997:100:2341-2346.
94. Toppari J, Larsen JC, Christiansen P et al: Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996(suppl 4):741-803.